制药
从元素/物相分析到分子结构解析
X 射线衍射(XRD)和 X 射线荧光(XRF)在药物发现和质量控制中发挥着关键作用。理学在单晶衍射仪器领域表现卓越这对于处理大分子和小分子均至关重要。我们提供从晶体筛选系统到三维结构精修的全流程解决方案,全面满足法规监管与非监管环境下的关键质量属性控制需求。
药品全生命周期
以成熟可靠的材料分析、鉴定与定量技术,助力您打造安全、高效、值得信赖的药品。
药物研发
Rigaku 为药物研发提供全面解决方案,通过解析导致疾病的蛋白质结构,协助设计新药候选分子。小角 X 射线散射仪(SAXS),以及适宜于小分子的独特 PDF 方法均可助力您推进药物研发进程。
了解更多 >
处方前研究
药物研发、设计、开发及制剂研究的各个阶段都高度依赖多种分析技术的综合运用。这些技术包括:用于获取结构信息的衍射技术、解析分子细节的光谱技术、测定元素组成的荧光分析,以及判断晶型的热分析技术。
了解更多 >
制剂研发
制剂研发过程复杂多变,存在多种技术路径与潜在风险。理学通过提供全面的分析工具与专业洞察,助力实现目标产品性能。我们的解决方案覆盖原子纯度、分子鉴定、空间结构、微观结构与物相行为表征,为制剂研究者精准赋能。
了解更多 >
生产与质量控制
理学通过多种分析技术确保持续稳定的药品质量。我们综合运用荧光、光谱、衍射及定量分析方法,监测原料混合均匀度与固态形式转变。此外,还可采用X射线CT显微成像解析三维微观结构,建立其与溶出行为、治疗效果的关联模型,为药品等效性研究提供关键依据。
了解更多 >应用领域
了解制药分析的主要应用
多晶型研究
为全面掌握活性分子的固态形态特性,需进行系统的多晶型筛选,以识别可能存在的不同晶型、水合物/溶剂化物及共晶形式,并明确其热力学相互关系。理学提供一系列可定制化的衍射、光谱及热分析系统,以满足从简略到全面的筛选需求。
了解更多 >应用说明
探索成功应用案例,应对研发与生产中的挑战
-
XRD1003 - How to Evaluate Solid Pharmaceutical Drugs (3): Confirming Hydrates
-
XRD1002 - How to Evaluate Solid Pharmaceutical Drugs (2): Confirming the Presence/absence of Amorphous Substances
-
XRD1001 - How to Evaluate Solid Pharmaceutical Drugs (1): Confirming the crystal form of an API
-
XCT2102 - Submicron CT for the Pharmaceutical Industry
-
TA6017 - Evolved Gas and Kinetic Analysis of Acetylsalicylic Acid
-
TA6006 - Thermal Behavior Analysis of Over-the-counter (OTC) Drugs
-
TA6005 - Comparison of Drugs
-
TA-TGMS-Pharm - TG-MS Analysis for Thermal Behavior of Commercialized PharmaceuticalProducts
-
SMX042 - In situ crystallization and diffraction experiments with the Insight Chips liquid nano-channel holder and XtaLAB Synergy-ED
-
SMX039 - The Absolute Structure of Light-atom-containing Molecules
-
SMX037 - Identification of a Fungicide Degradant using the XtaLAB Synergy-ED
-
SMX030 - Application of the Crystalline Sponge Method for Structure Determination of Persistent organic Pollutants of Agrochemical Degradation Products
-
SMX027 - Micro Powder Diffraction on XtaLAB Synergy Single Crystal Diffractometers
-
SMX010 - A Study of the Stereochemistry of Sucrose and a Phenidate Derivative using the Copper Microfocus Source of the XtaLAB Synergy-i
-
RAD006 - Pharmaceutical Excipients Identification with Handheld Raman
-
RACCT9045 - Tablet Crystallinity Analysis by X-ray CT
-
RACCT9044 - Rapid-release Pain Medication Capsule Comparison by X-ray CT
-
RACCT9043 - Multivitamin Tablet Analysis by X-ray CT
-
RACCT9042 - Microparticle Coating Analysis by X-ray CT
-
RACCT9041 - Famotidine Tablet Comparison by X-ray CT
-
RACCT9040 - Degradation of Sustained-release Dosage Tablet Imaged by X-ray CT
-
RACCT9039 - Compression Methods Comparison by X-ray CT
-
RACCT9038 - Brand Name vs Generic Atorvastatin Tablets Comparison by X-ray CT
-
RACCT9037 - Aspirin Tablet Coating Delamination Imaging by X-ray CT
-
PHRM0002 - In-Situ DSC-Humidity PXRD Analysis for Pharmaceuticals
-
PHRM0001 - Crystalline Sponge Method on XtaLAB Synergy Systems
-
EDXRF1933 - NEX DE Series—Catalysts Residue and Heavy Metal Screening in Pharma Formulation Process Chemistry
-
B-XRI1015 - Observation of Lyophilized Formulations by Micro X-ray CT
-
B-XRD1142 - Quantitative Analysis of Crystal Polymorphs by the DD Method
-
B-XRD1137 - Phase ID Analysis of Micro-impurities on the Surface of a Tablet by Micro-area XRD Measurements
-
B-XRD1133 - Observation of Phase Transition Behavior of Pharmaceutical Materials with a Benchtop XRD System
-
B-XRD1129 - Variable Humidity Measurement of a Drug Substance using XRD-DSC and a Humidity Controller
-
B-XRD1128 - Observation of Dehydration Behavior of a Drug Substance using TG-DTA and XRD-DSC
-
B-XRD1120 - Quantitative Analysis of Pharmaceutical Polymorphic Forms via the DD Method
-
B-XRD1114 - LOQ of Trace Impurities in API by the DD Method
-
B-XRD1081 - Quantitative Analysis of Polymorphic Impurities in a Drug Substance by the Calibration Method
-
B-XRD1060 - MiniFlex Measurement of Trace Samples
-
B-XRD1046 - Crystal Phase Identification of Pharmaceutical Materials in the Freeze Drying Process
-
B-XRD1043 - Powder Crystal Structure of Organic Crystals
-
B-XRD1035 - Crystal Structure Analysis of a Powder Sample of Pharmaceutical Cocrystals by the Rietveld Method
-
B-XRD1023 - Measurement of Pseudo-polymorph Impurities in Tablets
-
B-XRD1021 - Phase Changes of Pharmaceuticals as a Function of Temperature and Humidity
-
B-XRD1020 - Observation of Dehydration Process of Hydrate by XRD-DSC
-
B-TA2042 - Thermal Stability of Polyethylene Glycol Studied by TG-MS
-
B-TA1086 - Analysis of Polymorphic Transition of Carbamazepine -Sample Observation DSC, ChromTA (Chromatic Thermal Analysis)
-
B-TA1035 - Dehydration of Trehalose Dihydrate by STA
-
B-TA1027 - Water Absorption Behavior of Materials for Biomedical Application by HUM-TG
-
B-TA1013 - Mechanically Induced Amorphization in Trehalose Dihydrate by STA
-
B-TA1010 - Thermal Behavior of Caffeine by STA and DSC
-
B-TA1008 - Mechanochemical Effect in Caffeine
-
B-TA1003 - The Behavior of Water Absorption and Dehydration of Organic Materials
-
B-SCX1011 - High-Speed Measurement Of A Peptide Drug Using HyPix-Arc 150°